IP Library Granted Patent US 8,591,575
Granted Patent B2
US 8,591,575 · App. 11/692,890 · Granted Nov 26, 2013

Method of dilating a stenotic aortic valve and implanting a prosthetic valve

Inventor: Alain Cribier (Maromme, FR)
Assignee: Edwards Lifesciences PVT, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,591,575
App. No.
11/692,890
Granted
Nov 26, 2013
Kind
B2
Abstract

A method for treating a stenotic native aortic valve in a human heart is provided. The method comprises dilating the stenotic native aortic valve using a dilatation catheter and then deploying a prosthetic heart valve within the dilated stenotic native aortic valve. The prosthetic heart valve comprises a collapsible and expandable metallic stent and a valvular structure formed of a synthetic biocompatible material. The valvular structure is positioned substantially between the inlet and outlet ends of the stent for preventing the flow of blood in one direction. The prosthetic heart valve may further comprise an internal sleeve for creating a seal along at least a portion of the stent wall.

Claims (21)

1. A method for treating a stenotic native aortic valve in a human heart, comprising:

advancing a guidewire through the femoral artery and around the aortic arch in a direction against the flow of blood;

advancing a dilatation catheter over the guidewire, the dilatation catheter having an inflatable balloon disposed along a distal end portion;

dilating the stenotic native aortic valve by inflating the balloon in the native stenotic aortic valve to push aside the valvular leaflets of the stenotic native aortic valve;

withdrawing the dilatation catheter over the guidewire;

advancing a delivery catheter over the guidewire, the delivery catheter having a prosthetic heart valve disposed along a distal end portion thereof, the prosthetic heart valve including a collapsible and expandable metallic stent formed with intersecting bars which form zig-zag lines along upper and lower extremities of the stent, the stent having a substantially cylindrical shape when expanded in the native aortic valve and a collapsible and expandable valvular structure fixed to the stent along a coupling line, the valvular structure having open and closed positions for replacing the function of the native aortic valve, the valvular structure positioned entirely between the upper and lower extremities of the stent when in the closed position, the prosthetic heart valve further comprising an internal cover which forms a sleeve covering only a lower portion of the stent, the internal cover sewn to the valvular structure and to the bars of the stent for preventing passage of blood through spaces between the bars of the stent along the lower portion of the stent while blood is permitted to flow through spaces between the bars of the stent along an upper portion of the stent above the internal cover, wherein the spaces between the bars of the stent are covered by the internal cover only along the inner surface of the stent and only along the lower portion of the stent;

radially expanding the prosthetic heart valve in the dilated stenotic native aortic valve such that the intersecting bars of the stent embed into the valvular leaflets of the dilated stenotic native aortic valve;

withdrawing the delivery catheter over the guidewire; and

removing the guidewire.

2. The method of claim 1 , wherein the radial expansion of the prosthetic heart valve is performed by inflating a balloon disposed along the distal end portion of the delivery catheter.

3. The method of claim 2 , wherein the prosthetic valve is introduced into the femoral artery through an introducer.

4. The method of claim 3 , wherein the introducer is a 18 French introducer.

5. The method of claim 3 , wherein the introducer is a 16 French introducer.

6. The method of claim 3 , wherein the introducer is a 14 French introducer.

7. The method of claim 1 , wherein the valvular structure is formed with a synthetic biocompatible material.

8. The method of claim 1 , wherein the internal cover is formed with a synthetic biocompatible material.

9. The method of claim 8 , wherein the synthetic biocompatible material comprises polyethylene.

10. The method of claim 8 , wherein the synthetic biocompatible material comprises polyamide.

11. The method of claim 1 , wherein the stenotic native aortic valve is dilated to a diameter of at least about 20 millimeters before radially expanding the prosthetic heart valve.

12. The method of claim 1 , wherein the stent is viewable under fluoroscopy during radial expansion of the prosthetic heart valve.

13. The method of claim 1 , wherein, after radial expansion, the stent of the prosthetic heart valve has a constant diameter with a linear profile.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2011
From: CRIBIER, ALAIN
To: PERCUTANEOUS VALVE TECHNOLOGIES, INC.
Reel/Frame 026316/0939 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2011
From: CRIBIER, ALAIN
To: PERCUTANEOUS VALVE TECHNOLOGIES
Reel/Frame 026317/0032 →
CHANGE OF NAME Recorded Jun 3, 2010
From: PERCUTANEOUS VALVE TECHNOLOGIES, INC.
To: EDWARDS LIFESCIENCES PVT, INC.
Reel/Frame 024479/0730 →
Priority Claims (1)
EP 96402929 · Dec 31, 1996 · regional
Continuity (6)
Continuation 11110402 · Apr 20, 2005
Continuation 10139741 · May 2, 2002
Continuation 09795803 · Feb 28, 2001
Continuation 09345824 · Jun 30, 1999
Continuation PCTEP9707337 · Dec 31, 1997
Related Publication 20080009940A1 · Jan 10, 2008